All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This gene is a nuclear protein of the AlkB related non-haem iron and 2-oxoglutarate-dependent oxygenase superfamily but the exact physiological function of this gene is not known. Other non-heme iron enzymes function to reverse alkylated DNA and RNA damage by oxidative demethylation. Studies in mice and humans indicate a role in nervous and cardiovascular systems and a strong association with body mass index, obesity risk, and type 2 diabetes.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ1280 | Anti-FTO (CBXF-1235) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXF-1235 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1281 | Anti-FTO (CBXF-1236) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXF-1236 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1282 | Anti-FTO (CBXF-0952) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Cattle, Dog, Horse, Sheep | CBXF-0952 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1283 | Anti-FTO (FT86-4) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Rat, Mouse | FT86-4 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1284 | Anti-FTO (5-2H10) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | 5-2H10 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1285 | Anti-FTO (AG103) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | AG103 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1286 | Anti-FTO (FT62-6) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | FT62-6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1287 | Anti-FTO (FT342-1) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat | FT342-1 | Rat | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1288 | Anti-FTO (CBXF-2684) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXF-2684 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1289 | Anti-FTO (CBXF-1805) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXF-1805 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4704 | Anti-FTO (CBXF-1235) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXF-1235 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4705 | Anti-FTO (CBXF-1236) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXF-1236 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4706 | Anti-FTO (CBXF-0952) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Cattle, Dog, Horse, Sheep | CBXF-0952 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4707 | Anti-FTO (FT86-4) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Rat, Mouse | FT86-4 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4708 | Anti-FTO (5-2H10) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | 5-2H10 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4709 | Anti-FTO (AG103) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | AG103 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4710 | Anti-FTO (FT62-6) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | FT62-6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4711 | Anti-FTO (FT342-1) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat | FT342-1 | Rat | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4712 | Anti-FTO (CBXF-2684) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXF-2684 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4713 | Anti-FTO (CBXF-1805) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXF-1805 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION